Xylitol Topical Ocular Solution
AssigneeGSX Pharma LLC
InventorsStephen Sinclair, Joseph Greenberg
Life of this patent
Estimating the term…
Loading patent…
AssigneeGSX Pharma LLC
InventorsStephen Sinclair, Joseph Greenberg
Estimating the term…
A solution for ocular application containing xylitol. Topically applied to the eye, the solution improves the quality of the ocular tear film, and reduces the incidence of infectious organisms, including bacterial abnormal colonization, acanthamoeba and an assortment of infective virus types including SARS, SARS-Cov-2. The same solution may also be applied to eyes of contact lens wearers and within the contact lens storage solutions to reduce the incidence of infection and in eyes with sicca syndromes demonstrating tear film poor lipid quantity or quality with meibomian gland dysfunction and in eyes demonstrating evidence of inflammation of the margins or posterior lid mucosal surfaces indicating blepharitis. The solution may be also applied to the lid margins with heat and ocular scrubbing massage in the case of eyes demonstrating blepharitis.
A substance in the form of an aqueous solution comprising:
An aqueous solution for extra-ocular storage of contact lenses that demonstrates reduction in the incidence of bacterial, viral or acanthamoeba growth on the surface of the contact lenses comprising:
A substance in the form of an aqueous solution comprising:
A substance in the form of an aqueous solution comprising:
Dependencies are inferred from the claim text.